WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017205661) METHOD OF TREATING CANCER BY TARGETING MYELOID-DERIVED SUPPRESSOR CELLS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/205661    International Application No.:    PCT/US2017/034537
Publication Date: 30.11.2017 International Filing Date: 25.05.2017
IPC:
A61K 31/519 (2006.01), A61K 51/04 (2006.01), A61K 38/07 (2006.01)
Applicants: PURDUE RESEARCH FOUNDATION [US/US]; 1801 Newman Road West Lafayette, Indiana 47906 (US).
ENDOCYTE, INC. [US/US]; 3000 Kent Avenue West Lafayette, Indiana 47906 (US)
Inventors: LOW, Philip Stewart; (US).
WANG, Bingbing; (US).
LEAMON, Christopher Paul; (US).
LU, Yingjuan J.; (US).
WHEELER II, Leroy W.; (US)
Agent: BALL, Rebecca L.; (US).
LIPTAK, Vincent P.; (US)
Priority Data:
62/341,587 25.05.2016 US
Title (EN) METHOD OF TREATING CANCER BY TARGETING MYELOID-DERIVED SUPPRESSOR CELLS
(FR) PROCÉDÉ DE TRAITEMENT DU CANCER PAR CIBLAGE DE CELLULES SUPPRESSIVES D'ORIGINE MYÉLOÏDE
Abstract: front page image
(EN)The invention described herein relates to methods for treating a cancer using one or more compounds comprising a folate receptor binding ligand attached to a drug via a linker. More particularly, the invention described herein relates to methods for treating a cancer using one or more compounds comprising a folate receptor binding ligand attached to a drug via a linker to target myeloid-derived suppressor cells.
(FR)L'invention concerne des procédés de traitement d'un cancer à l'aide d'un ou de plusieurs composés comprenant un ligand de liaison au récepteur de folate fixé à un médicament par l'intermédiaire d'un lieur. Plus particulièrement, l'invention concerne des procédés de traitement d'un cancer à l'aide d'un ou de plusieurs composés comprenant un ligand de liaison au récepteur de folate fixé à un médicament par l'intermédiaire d'un lieur pour cibler des cellules suppressives d'origine myéloïde.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)